Clinical Trial Update: Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for tivozanib in advanced or non-resectable hepatocellular carcinoma (HCC) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tivozanib (tivozanib)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Advanced Adult Hepatocellular Carcinoma, Non-Resectable Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-28